It has been shown that the activity of certain matrix metalloproteases, such as MMP-2 (gelatinase A), MMP-9 (gelatinase B), MMP-14 (matrix metalloproteinase 14) is related to the pathophysiology of high-grade gliomas. The gene discussed is MMP9; the disease is central nervous system cancer.